...
首页> 外文期刊>Radiology >Recurrent carcinoma after breast conservation: diagnosis with stereotaxic core biopsy.
【24h】

Recurrent carcinoma after breast conservation: diagnosis with stereotaxic core biopsy.

机译:保留乳房后复发的癌症:立体定向核心活检诊断。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the utility of stereotaxic core biopsy (SCB) in diagnosing recurrent carcinoma after breast-conserving therapy (BCT). MATERIALS AND METHODS: Of 316 patients evaluated with SCB, 17 (5%) had nonpalpable lesions in breasts previously treated with BCT. Surgical correlation was obtained in 14 patients. SCBs were performed with digital stereotaxic equipment, with patients prone. RESULTS: Carcinoma detected at SCB in 11 (79%) of 14 patients included infiltrating ductal carcinoma (IFDC) in five, ductal carcinoma in situ (DCIS) in five, and infiltrating lobular carcinoma (ILC) in one. Surgical histopathologic findings agreed with core biopsy findings in 10 of these patients. In one patient with two SCB-proved foci of IFDC, one IFDC was identified at mastectomy. In two (14%) patients, SCB revealed atypical ductal hyperplasia; however, DCIS was found at surgical biopsy. In one patient, the SCB finding of fat necrosis was confirmed at surgical biopsy. CONCLUSION: These data suggest that SCB may be useful in diagnosing recurrent carcinoma in the conservatively treated breast.
机译:目的:评价立体定位活检(SCB)在保乳治疗(BCT)后诊断复发癌中的实用性。材料与方法:在316名接受SCB评估的患者中,有17名(5%)先前接受BCT治疗的乳房有不可触及的病变。 14例患者获得了手术相关性。 SCB使用数字立体定位设备进行,患者容易俯卧。结果:14例患者中有11例在SCB检测到的癌包括5例浸润性导管癌(IFDC),5例浸润性导管原位癌(DCIS)和1例浸润性小叶癌(ILC)。外科组织病理学发现与其中10例患者的核心活检发现一致。在一名患有两个SCB验证的IFDC病灶的患者中,在乳房切除术中发现了一个IFDC。在两名(14%)患者中,SCB表现为非典型的导管增生。但是,在手术活检中发现了DCIS。一名患者在手术活检中证实了SCB脂肪坏死的发现。结论:这些数据表明,SCB可能在诊断保守治疗的乳腺复发癌中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号